Haritaki | whatsinit

About

What it is and where it shows up.

Haritaki is the dried fruit of Terminalia chebula Retz. (family Combretaceae), a medium-sized deciduous tree native to South and Southeast Asia, widely distributed in India up to 1500 m altitude. It has been used for centuries in Ayurvedic, Unani, Siddha, and Tibetan medicine as a digestive tonic, laxative, antimicrobial, and antioxidant agent, and is a principal constituent of the classic Ayurvedic formulation Triphala.

Safety summary

The regulatory and scientific consensus.

Haritaki is generally well tolerated in traditional and short-term clinical use; a randomized crossover trial in healthy volunteers found a single oral dose of 1000 mg was well tolerated with no adverse events recorded. Its high hydrolysable tannin content (chebulic acid, chebulinic acid, chebulagic acid, gallic acid) may inhibit iron and mineral absorption with prolonged or high-dose use, and large doses may exert pronounced laxative or purgative effects. No formal Acceptable Daily Intake (ADI) has been established by any major regulatory authority (EFSA, FDA, JECFA), and safety data for pregnancy, lactation, and paediatric populations remain insufficient.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Permitted as a botanical/herbal ingredient under FSS (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Foods and Novel Foods) Regulations, 2016. Recognised as a traditional Ayurvedic herb; no specific maximum daily dose fixed for food use. Products making health claims must comply with FSSAI claim guidelines.source
EFSA (European Food Safety Authority) (European Union)	Under_review	Terminalia chebula is not listed as an approved novel food or food supplement ingredient in the EU Novel Food Catalogue. Any use as a food ingredient or supplement in the EU would require a novel food safety authorisation under Regulation (EU) 2015/2283 prior to placement on the market.source
FDA (Food and Drug Administration) (United States)	Under_review	Not listed as an approved food additive or GRAS substance in 21 CFR Parts 172, 182, or 184. Commercially marketed in the US as a dietary supplement ingredient under DSHEA (21 USC §321(ff)); no food additive petition or GRAS notice for direct food use identified in FDA records.source

Who should approach with care

Whose guidance would steer them away.

Pregnancy — Traditionally contraindicated in Ayurvedic practice during pregnancy due to strong laxative and purgative properties; no controlled clinical safety data exist for pregnant women.

Lactation — No clinical data on transfer of Haritaki constituents (tannins, gallic acid) into breast milk or safety for nursing infants; precautionary avoidance is recommended.

Infants — No clinical safety data for infant populations; high hydrolysable tannin content may critically impair iron and mineral absorption during early development.

Children — Tannins in Haritaki may inhibit iron absorption in growing children; no pediatric pharmacokinetic or safety trials have been conducted.

Kidney Disease — High tannin and polyphenol load may impose additional metabolic burden on compromised renal function; clinical evidence in this population is absent.

Research citations

The sources behind this verdict.

1PubMed. Haritaki (Chebulic myrobalan) and its varieties. pmc.ncbi.nlm.nih.gov
2PubMed. A randomized, double-blind, placebo-controlled, cross-over study to evaluate analgesic activity of Terminalia chebula in healthy human volunteers using a mechanical pain model. ncbi.nlm.nih.gov
3PubMed. A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease. pmc.ncbi.nlm.nih.gov
4PubMed. A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz, 2022. pubmed.ncbi.nlm.nih.gov
5PubMed. Hypolipidemic activity of haritaki (Terminalia chebula) in atherogenic diet induced hyperlipidemic rats, 2010. pubmed.ncbi.nlm.nih.gov

Independently researched5 citations